Catalent reportedly to buy Paragon Bioservices for $1.2 billion

Catalent said on Monday it would buy privately held gene therapy-focused Paragon Bioservices Inc in an all-cash deal for $1.2 billion.

from Deals and IPOs https://cnb.cx/2GnAf9q